Why Is Procainamide So Hard to Find? [Explained for 2026]

If you or a loved one has been prescribed procainamide—or if you're a clinician trying to source it for your facility—you may have run into availability problems. Procainamide is a critical antiarrhythmic medication that has faced supply disruptions in the past and can be difficult to locate at certain pharmacies and hospital formularies today. Here's what's driving those challenges and what you can do about it.

What Is Procainamide and Who Needs It?

Procainamide is a Class IA antiarrhythmic drug used to treat life-threatening cardiac arrhythmias, including sustained ventricular tachycardia, supraventricular tachycardias, atrial flutter, atrial fibrillation, and Wolff-Parkinson-White syndrome. It works by blocking sodium channels in the heart, slowing down abnormal electrical signals that cause dangerous rhythm disturbances.

Procainamide injection (100 mg/mL and 500 mg/mL) is primarily administered in hospital emergency departments, intensive care units, and cardiac care settings. The oral formulation (Pronestyl tablets and capsules) was discontinued from commercial production in the United States, making the injectable form the only commercially available option for most patients.

Why Did Procainamide Go Into Shortage?

In 2017, Pfizer—one of the major manufacturers of procainamide injection—experienced manufacturing delays that triggered a national shortage. The FDA tracked the disruption closely. Nexus Pharmaceuticals stepped in and launched their procainamide injection in October 2017 to help fill the gap. By April 2018, all marketed presentations were reported as available.

That episode highlights a recurring risk with specialty injectable medications: when only a handful of manufacturers produce a drug and one has a quality or production issue, the entire market can be affected quickly. Procainamide is made by a small number of manufacturers—including Amphastar, Nexus Pharmaceuticals, and Pfizer—so disruptions at any one facility can ripple across the supply chain.

Is Procainamide Still Hard to Find in 2026?

As of 2026, there is no active FDA-listed national shortage of procainamide injection. However, that doesn't mean every pharmacy or hospital formulary stocks it readily. Several factors can still create access difficulties:

Limited retail pharmacy stocking. Because procainamide is primarily used in hospitals, many community pharmacies don't carry it at all.

Oral form discontinuation. Pronestyl tablets and Procanbid extended-release tablets are no longer commercially manufactured in the US. Patients needing oral procainamide must turn to compounding pharmacies, which are not universally available.

Hospital formulary gaps. Smaller community hospitals may not stock procainamide injection routinely, preferring amiodarone or lidocaine as their primary IV antiarrhythmics.

Regional supply variation. Even when no national shortage exists, localized supply tightness can make it difficult to find specific concentrations or vial sizes in certain areas.

The Oral Procainamide Problem

For patients who previously relied on oral procainamide tablets or capsules for long-term arrhythmia management, the discontinuation of commercial oral formulations has been a significant hurdle. These patients must now work with their cardiologist and a compounding pharmacy to obtain an oral formulation—adding cost, complexity, and potential delays to their care.

Not all compounding pharmacies are equipped to make procainamide oral dosage forms. Finding a qualified pharmacy that can compound procainamide capsules or a liquid suspension requires research—and that's where tools like medfinder can help.

39,018+ patients found their medications in stock

39K+

Find Procainamide In Stock Today →

Why Procainamide Stocking Varies So Much by Pharmacy

Pharmacies—especially retail chains—stock drugs based on demand. Procainamide injection is rarely dispensed at the retail level since it's typically administered in clinical settings. When a patient or caregiver does need to find an outpatient supply, they may be surprised to find that most chain pharmacies don't stock it at all.

This means calling around is almost inevitable—unless you use a service that does it for you. medfinder calls pharmacies in your area on your behalf to check which ones can fill your procainamide prescription, saving you hours of phone calls.

What Happens When You Can't Find Procainamide?

If you or your provider cannot locate procainamide, here are the steps most commonly recommended:

Contact your cardiologist or electrophysiologist immediately—do not skip doses or delay treatment for a life-threatening arrhythmia condition.

Ask your prescriber about alternative antiarrhythmic agents such as amiodarone, lidocaine, sotalol, or quinidine if procainamide is unavailable. Read our full guide to procainamide alternatives here.

If you need compounded oral procainamide, ask your doctor for a referral to an accredited PCAB-certified compounding pharmacy.

Use medfinder to call pharmacies in your area and find one that has your medication in stock without spending hours on hold.

Skip the calls, skip the stress.

Find Procainamide In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

How medfinder Can Help

When you need to find a specific medication like procainamide at a pharmacy near you, medfinder does the legwork for you. You provide your medication, dose, and location, and medfinder calls pharmacies in your area to find out which ones can fill your prescription. Results are texted directly to you—no hold music, no runaround.

For more tips, see our guide on how to find procainamide in stock near you.

Bottom Line

Procainamide isn't in a national shortage today, but its limited retail distribution, the discontinuation of oral forms, and its specialty-only status mean patients and providers can still face real access challenges. Understanding why the supply is limited—and knowing where to look—can make all the difference when you need this critical medication quickly.